In the US, Ramipril (ramipril systemic) is a member of the drug class angiotensin converting enzyme inhibitors and is used to treat Diabetic Kidney Disease, Heart Attack, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.
US matches:
- Ramipril
- Ramipril Capsules
UK matches:
- Ramipril 1.25mg, 2.5mg, 5mg & 10mg Capsules
- Ramipril 1.25mg, 2.5mg, 5mg & 10mg Tablets
- Ramipril Capsules 1.25mg, 2.5mg, 5mg, 10mg (Actavis UK Ltd)
- Ramipril Tablets 1.25mg, 2.5mg, 5mg, 10mg (Actavis UK Ltd)
- Ramipril 1.25 mg Capsules (SPC)
- Ramipril 1.25mg Tablets (SPC)
- Ramipril 10 mg Capsules (SPC)
- Ramipril 10mg Tablets (SPC)
- Ramipril 2.5 mg Capsules (SPC)
- Ramipril 2.5mg Tablets (SPC)
- Ramipril 5 mg Capsules (SPC)
- Ramipril 5mg Tablets (SPC)
Ingredient matches for Ramipril
Ramipril
Ramipril (BAN, DCF, USAN) is known as Ramipril in the US.
Hydrochlorothiazide
Hydrochlorothiazide is reported as an ingredient of Ramipril in the following countries:
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
SPC | Summary of Product Characteristics (UK) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and
International Nonproprietary Names.